Pancreatic cancer clinical trials

Explore recruiting pancreatic cancer clinical trials.

Recruiting pancreatic cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatic cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PaTcH Trial: A phase 2 study to explore primary and emerging resistance mechanisms in patients with metastatic refractory Pancreatic cancer treated with Trametinib and Hydrochloroquine.

Ireland

Therapeutic exploratory (Phase II) EU CTIS Study details

A First in human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients with Advanced/Metastatic Pancreatic Cancer

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

SARUPANC - A multicentric, single arm, phase II trial assessing the efficacy of suraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Thrombosis prophylaxis and coagulation activation during neoadjuvant treatment in pancreatic cancer - Association to prognosis and recurrence.

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Pancreatic cancer trials by city

Pancreatic cancer in Toronto Pancreatic cancer in Vancouver Pancreatic cancer in Montreal Pancreatic cancer in Calgary Pancreatic cancer in Edmonton Pancreatic cancer in Ottawa Pancreatic cancer in Winnipeg Pancreatic cancer in Quebec City Pancreatic cancer in Hamilton Pancreatic cancer in Kitchener Pancreatic cancer in London Pancreatic cancer in Halifax Pancreatic cancer in New York Pancreatic cancer in Los Angeles Pancreatic cancer in Chicago Pancreatic cancer in Houston

Pancreatic cancer clinical trials

Recruiting pancreatic cancer studies right now

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Increasing Germline Genetic Testing for Patients With Cancer

Also recruiting in Europe

PaTcH Trial: A phase 2 study to explore primary and emerging resistance mechanisms in patients with metastatic refractory Pancreatic cancer treated with Trametinib and Hydrochloroquine.

A First in human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients with Advanced/Metastatic Pancreatic Cancer

SARUPANC - A multicentric, single arm, phase II trial assessing the efficacy of suraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer

Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer

Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1)

Thrombosis prophylaxis and coagulation activation during neoadjuvant treatment in pancreatic cancer - Association to prognosis and recurrence.

Pancreatic cancer trials by city

Other conditions